NEW YORK (GenomeWeb) – Molecular diagnostics firm IntegraGen today announced a distribution deal with Genoma to commercialize IntegraGen's Arisk autism spectrum disorder genetic risk assessment test outside the US. 

Financial and other terms of the deal were not disclosed. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.